12879_2017_2831_MOESM1_ESM.docx (12.46 kB)
Additional file 1: of Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients
journal contribution
posted on 2017-11-16, 05:00 authored by Nicola Gianotti, Andrea Poli, Silvia Nozza, Laura Galli, Nadia Galizzi, Marco Ripa, Marco Merli, Alessia Carbone, Vincenzo Spagnuolo, Adriano Lazzarin, Antonella CastagnaSpecific PIs and NNRTIs ongoing at baseline. (DOCX 12Â kb)